EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Lobectomy improves disease-free survival over sublobar resection for high-risk stage IA non−small cell lung cancer

Raul Caso, Nanruoyi Zhou, Matthew Skovgard, Nicolas Toumbacaris, Kay See Tan, Prasad S Adusumilli, Manjit S Bains, Matthew J Bott, Robert J Downey, James Huang, James M Isbell, Daniela Molena und 6 weitere

The Journal of Thoracic and Cardiovascular Surgery · 2026-02 · 171 (2) · 510-518.e2

DOI: 10.1016/j.jtcvs.2025.08.024 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2026-02. Verfasst von Raul Caso und 17 weiteren Autor:innen. Beteiligte Einrichtung: Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pneumonectomy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To investigate disease-free survival (DFS) of sublobar resection versus lobectomy for stage IA non-small cell lung cancer (NSCLC) with preoperative high-risk features. METHODS: Data were abstracted from a prospective database to identify patients with clinical T1a-T1bN0M0 NSCLC (≤2 cm) who underwent lobectomy or sublobar resection (wedge resection or segmentectomy). 1:1 propensity matching was used to balance the dataset for forced expiratory volume in 1 second ≥60% and high-risk features: cT1b versus cT1a, standard uptake value of the primary tumor on positron emission tomography, solid versus subsolid tumor texture on computed tomography, and micropapillary/solid histology. The primary outcome was DFS. RESULTS: In total, 825 patients met inclusion criteria: 52% (n = 426) patients underwent lobectomy and 48% (n = 399) of patients underwent sublobar resection (45% segmentectomy, 55% wedge resection). Lobectomy was associated with more preoperative high-risk features: cT1b (P < .001), greater standard uptake value (P < .001), solid tumor texture on computed tomography (P < .001), and micropapillary/solid histology (P < .001). In total, 660 patients were included in the matched analysis with all high-risk features balanced. Nodal upstaging (N1) was greater in patients who underwent lobectomy (9.1% vs 3.4%, P = .004). Five-year DFS (85% vs 74%, P = .12) was equivalent in the matched cohort. Lobectomy was protective for recurrence in the presence of 2 or greater high-risk features: sublobar resection patients with 2 high-risk features (hazard ratio, 1.77; 95% confidence interval, 1.13-2.76, P = .012) or 3-4 high-risk features (hazard ratio, 1.97; 95% confidence interval, 1.25-3.10, P = .004) had worse DFS. CONCLUSIONS: Lobectomy should be considered over sublobar resection for stage IA NSCLC ≤2 cm in the presence of multiple high-risk features.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsPneumonectomyHumansMaleFemaleMiddle AgedAgedNeoplasm StagingDisease-Free SurvivalRisk FactorsTreatment OutcomeRetrospective StudiesPropensity ScoreTime FactorsDatabases, Factual

Stichwörter der Autor:innen

high-risknon−small cell lung cancersublobar resection

Autor:innen und Institutionen

  • Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address: grayk@mskcc.org.

Förderung

  • NCI NIH HHS
  • National Institutes of Health
  • National Cancer Institute

Zitieren

APA

Caso, R., Zhou, N., Skovgard, M., Toumbacaris, N., Tan, K. S., Adusumilli, P. S., Bains, M. S., Bott, M. J., Downey, R. J., Huang, J., Isbell, J. M., Molena, D., Park, B. J., Rocco, G., Rusch, V. W., Sihag, S., Jones, D. R., & Gray, K. D. (2026). Lobectomy improves disease-free survival over sublobar resection for high-risk stage IA non−small cell lung cancer. The Journal of Thoracic and Cardiovascular Surgery, 171(2), 510-518.e2. https://doi.org/10.1016/j.jtcvs.2025.08.024

Vancouver

Caso R, Zhou N, Skovgard M, Toumbacaris N, Tan KS, Adusumilli PS, et al. Lobectomy improves disease-free survival over sublobar resection for high-risk stage IA non−small cell lung cancer. The Journal of Thoracic and Cardiovascular Surgery. 2026;171(2):510-518.e2. doi:10.1016/j.jtcvs.2025.08.024

BibTeX
@article{Caso2026,
  author = {Caso, Raul and Zhou, Nanruoyi and Skovgard, Matthew and Toumbacaris, Nicolas and Tan, Kay See and Adusumilli, Prasad S and Bains, Manjit S and Bott, Matthew J and Downey, Robert J and Huang, James and Isbell, James M and Molena, Daniela and Park, Bernard J and Rocco, Gaetano and Rusch, Valerie W and Sihag, Smita and Jones, David R and Gray, Katherine D},
  title = {Lobectomy improves disease-free survival over sublobar resection for high-risk stage IA non−small cell lung cancer},
  journal = {The Journal of Thoracic and Cardiovascular Surgery},
  year = {2026},
  volume = {171},
  number = {2},
  pages = {510--518.e2},
  doi = {10.1016/j.jtcvs.2025.08.024}
}
Kostenlos starten →